Trevena Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Chesterbrook PA United States (2007)

Organization Overview

First Clinical Trial
2010
NCT01187836
First Marketed Drug
2020
oliceridine
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

TREVENA | Trevena Inc.